SCHEMBL20004984

SCHEMBL20004984

CC(C)c1ccc(CN(C)CCI)cc1

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PYCR1 P32322 4/20 0.57
KDM4E B2RXH2 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
IDO1 P14902 2/20 0.40
HIF1A Q16665 3/20 0.39
CARM1 Q86X55 1/20 0.39
PRMT6 Q96LA8 1/20 0.39
PRMT8 Q9NR22 1/20 0.39
ALDH1A1 P00352 1/20 0.39
SIGMAR1 Q99720 2/20 0.38
CNR2 P34972 1/20 0.37
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20004363 0.81 PYCR1 (0.57) PYCR1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL22537608 0.79 PYCR1 (0.54) PYCR1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL18714778 0.79 PYCR1 (0.54) PYCR1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL17193942 0.79 PYCR1 (0.62) PYCR1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL16980535 0.77 SIGMAR1 (0.56) PYCR1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL16980543 0.77 PYCR1 (0.61) PYCR1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL16980545 0.77 PYCR1 (0.61) PYCR1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL6894409 0.76 HRH3 (0.58) PYCR1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL14019833 0.74 SIGMAR1 (0.56) PYCR1SIGMAR1
SCHEMBL21158890 0.74 HIF1A (0.50) PYCR1KDM4EMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018055316-A1 COMPOUNDS FOR USING IN IMAGING AND PARTICULARLY FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISEASES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-03-29 WO disclosed